Welcome to an insightful conversation with Dr. Ivan Kairatov, a distinguished neurosurgeon renowned for his expertise in rare skull base tumors and innovative surgical techniques. With a focus on sellar chondrosarcomas—a particularly uncommon and challenging condition—Dr. Kairatov has been at the
The realm of hemophilia treatment is witnessing a transformative wave, with innovative therapies challenging the status quo of managing this genetic blood clotting disorder, which has burdened patients for decades with frequent infusions to replace missing clotting factors. Now, a newly approved
Mantle cell lymphoma (MCL), a rare yet aggressive form of blood cancer, affects approximately one in every 100,000 individuals annually, falling within the broader category of lymphoma, which ranks as the sixth most common cancer worldwide. Despite its relative rarity, the disease poses a
Drug discovery has long been a daunting endeavor, with the staggering statistic that developing a single new drug can cost upwards of $1 billion and take over a decade to reach the market. Imagine a world where this timeline is slashed, costs are dramatically reduced, and even smaller research
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, particularly in cutting-edge technologies and innovations in the industry. Today, we’re diving into a groundbreaking advancement in cancer treatment—a new formulation of
Imagine a world where life-saving treatments for cancer, autoimmune diseases, and metabolic disorders no longer require hours of intravenous infusions in a clinical setting, allowing patients to administer their medications at home with a quick injection, reclaiming time and autonomy. This scenario
